Patent details

EP2344164 Title: USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZOÖ1,2-CÜQUINAZOLINES FOR THE TREATMENT OF MYELOMA

Basic Information

Publication number:
EP2344164
PCT Application Number:
PCT/EP/2009/006586
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097784664
PCT Publication Number:
WO/2010/034414
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZOÖ1,2-CÜQUINAZOLINES FOR THE TREATMENT OF MYELOMA
French Title of Invention:
UTILISATION DE 2,3-DIHYDROIMIDAZOÖ1,2-CÜQUINAZOLÉINES SUBSTITUÉES POUR LE TRAITEMENT D'UN MYÉLOME
German Title of Invention:
VERWENDUNG VON SUBSTITUIERTEN 2,3-DIHYDROIMIDAZOÖ1,2-CÜQUINAZOLINEN ZUR BEHANDLUNG VON MYELOM
SPC Number:

Dates

Filing date:
11/09/2009
Grant date:
15/07/2015
EP Publication Date:
15/07/2015
PCT Publication Date:
01/04/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/07/2011
EP B1 Publication Date:
15/07/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/09/2015
Expiration date:
11/09/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/09/2009
 
 

Name:
Bayer Intellectual Property GmbH
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

Name:
LIU Ningshu
Address:
Germany (DE)

Priority

Priority Number:
08164988
Priority Date:
24/09/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/519;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages